| Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery (NCT03433469) | University of California, San Francisco | 2018-07-31 |
| Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery (NCT02262325) | Ohio State University Comprehensive Cancer Center | 2015-06-08 |
| Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non-small Cell Lung Cancer and Their Family Caregivers (NCT02243748) | City of Hope Medical Center | 2015-02-01 |
| Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer (NCT02059889) | Virginia Commonwealth University | 2014-07-01 |
| Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC (NCT02059967) | Virginia Commonwealth University | 2014-03-01 |
| Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients (NCT01999881) | University of Wisconsin, Madison | 2013-12-01 |
| Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer (NCT01741636) | City of Hope Medical Center | 2013-01-01 |
| Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer (NCT01707823) | Vanderbilt-Ingram Cancer Center | 2012-10-01 |
| An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT01711697) | Emory University | 2012-09-04 |
| Study to Evaluate NA-NOSE for Monitoring and Detecting Recurrence in Early Stage Lung Cancer (NCT01840150) | Fox Chase Cancer Center | 2012-08-23 |
| Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy (NCT01595074) | National Cancer Institute (NCI) | 2012-05-01 |
| Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery (NCT01345851) | Jonsson Comprehensive Cancer Center | 2011-03-23 |
| Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer (NCT01457469) | Wake Forest University Health Sciences | 2011-01-01 |
| Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection (NCT00087269) | National Cancer Institute (NCI) | 2004-12-01 |
| Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery (NCT00049543) | National Cancer Institute (NCI) | 2002-09-01 |